🇸🇪 Stockholm, here we come!
MSInsight is proud to be a Sponsor Partner of the 10th Meeting of the EHTG – European Hereditary Tumour Group, […]
MSInsight is proud to be a Sponsor Partner of the 10th Meeting of the EHTG – European Hereditary Tumour Group, […]
🏆 Being recognized among the promising companies in oncology by the Paris Saclay Cancer Cluster (PSCC), the European oncology cluster, […]
Join us on June 19th at Paris Expo Porte de Versailles, Booth 3H19, on the Université Paris-Saclay space. Our CEO […]
We’re honored to be selected among the 10 laureates of the first BOOST Grant cohort by the Paris Saclay Cancer […]
Every year, the editorial team at Challenges, one of France’s leading business magazines, selects 100 of the most promising French […]
We’re proud to announce a deployment of #MSIcare at CHU Rennes, one of France’s university hospitals. The objective: evaluate […]
🎤 On March 17th, our CEO, Arnaud Cutivet will be pitching MSInsight at BioLabs European Investor Day in Paris. An […]
We are now ISO 13485:2016 certified – the international gold standard for medical device quality management systems. In medical diagnostics, […]
We’re excited to announce a major step in our long-standing collaboration with the « Microsatellite Instability and Cancer » research team at […]
MSInsight has been selected to join 21st, the deeptech accelerator by CentraleSupélec, one of France’s most prestigious engineering school. This […]